Publication

Considerations when advertising the health benefits of your products
Canada | Publication | April 30, 2020 - 10 AM ET
Claims for protection against COVID-19 will need to be pre-approved by Health Canada. It has continued to state that: “Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease,” which includes vaccines, drugs, natural health products, medical devices, or cleaning products such as antiseptics, disinfectants or sanitizers.
The Competition Bureau has taken action against companies selling filters or air purifiers that claim to filter out coronavirus. Health Canada has also begun publishing a list of COVID-19-related advertising incidents where they have taken compliance and enforcement action. The list outlines products and corresponding companies or advertising media that were found to engage in non-compliant marketing. Health Canada has taken compliance and enforcement actions against these organizations, as required. The list includes advertising incidents that are currently under review or have been resolved.
Opportunities for compliant COVID-19 advertising
Notwithstanding the above, there does remain an appropriate and compliant way to market products and their ability to provide health benefits in direct relation to COVID-19 and the infectious agent, SARS-CoV-2.
For example, Health Canada has stated that disinfectant products meeting efficacy standards for emerging viral pathogens could make indirect COVID-19 efficacy claims for SARS-CoV-2. Such products include those where Health Canada has approved the following claims on the label:
- Claims the product is a broad-spectrum virucide
- A specific claim against non-enveloped viruses of the picornaviridae, caliciviridae, astroviridae, reoviridae, or papillomaviridae families or
- A specific claim against a specific coronavirus, such as
o MERS-CoV
o SARS-CoV
o human coronavirus strain 229E
Another method to allow direct COVID-19 claims arose under an interim order issued by the minister of health on March 18. The order's intention was to enable an expedited review of medical devices indicated to diagnose, treat, mitigate or prevent COVID-19. While an authorization under the order is limited to medical devices, there may be an opportunity for a product manufacturer to submit evidence and supporting documentation to allow the product to be represented for use specifically for COVID-19.
It is clear Health Canada and the Competition Bureau continue to remain vigilant in monitoring and taking action against false, misleading or deceptive marketing practices related to COVID-19. It is important to remain compliant, while developing marketing materials to minimize business disruption and maintain a brand’s reputation and customer confidence.
Recent publications
Publication
Contratti a termine - Esenzione dal cosiddetto “Stop & Go”
Lo Stop & Go in relazione ai contratti a tempo determinato (spiegare) non si applica ai “lavoratori occupati in attività stagionali”.
Publication
Periodo di prova e contratti a tempo determinato
Il Collegato Lavoro prevede che, fatte salve le previsioni più favorevoli della contrattazione collettiva, la durata del periodo di prova per i rapporti di lavoro a tempo determinato è fissata in 1 giorno di effettiva prestazione ogni 15 giorni di calendario a partire dalla data di inizio del rapporto di lavoro.
Subscribe and stay up to date with the latest legal news, information and events . . .